Menu Search
Equities

Limes Schlosskliniken AG

LIKX:GER

Limes Schlosskliniken AG

Actions
  • Price (EUR)344.00
  • Today's Change2.00 / 0.58%
  • Shares traded0.00
  • 1 Year change0.00%
  • Beta0.4268
Data delayed at least 15 minutes, as of May 31 2024 16:36 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Limes Schlosskliniken AG is a Germany-based company. The Company engages in the Operation of clinics and healthcare facilities. This includes the provision of management and administrative services for other companies, in particular clinic operating companies, as well as businesses that directly serve and promote this company purpose.

  • Revenue in EUR (TTM)37.96m
  • Net income in EUR3.40m
  • Incorporated2015
  • Employees207.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		LIKX:GER since
announced		Transaction
value
Clinicum Alpinum AGDeal completed13 Jul 202313 Jul 2023Deal completed-0.58%--
Data delayed at least 15 minutes, as of May 31 2024 16:36 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.